‘Winner’ to patsy: what the radical insurance reforms could mean for the patient Neither cutting broker commissions nor mandating patient co-pay is a sure cure for increasing medical costs. But that’s about the only choice right now

Jewellery makers find a magic wand to wish away their woes Struggling with cash flow, manufacturers are using more than half of their IPO proceeds to pay off debt or to buy more inventory

New-age venture capital would rather manufacture founders than find them From Entrepreneurs First’s co-founder speed dates to The Foundery’s idea vault, a new wave of venture studios believe that plug-and-play founders are safer for their portfolios

Without a UPI, Africa pays a toll on cash. Airtel Money collects it Airtel earns about $373 million by charging Africans when they withdraw cash. As countries start building their own UPI though, that toll may disappear Tune in to today's Daybreak.

Nike seeks a silver lining in India While Indian brands are using the China playbook to try to become the next Nike, Nike now wants to replicate its China model in India

Pocket FM won’t stop throwing things at the wall The audio-series company dabbled in novels, then microdramas, and now AI. In the process, it claims it has doubled its annualised revenue to over $500 million

To treat autism in India, this chain has to rely on American patients Mom’s Belief couldn’t grow fast enough on its Indian therapy centres alone. How it got around that shows why care for neurodevelopmental disorders is so hard to scale

Ajio wants to course-correct, but Reliance Retail’s shadow looms large Sandeep Karwa has the experience to fix Ajio, but first he must struggle with a parent company that holds the purse strings Tune in to today's Daybreak.

Retail investors piled into the unlisted market’s favourite stock. Regret followed NSE’s listing was so underwhelming that it has shaken faith even in safe-sounding names that are next in line to list, like Zepto and OYO